Animal Models of Transfusion-Related Acute Lung Injury

Transfusion Medicine Reviews

Volumn 23, Issue 1, 2009, Pages 13-24

  Lögdberg, Lennart E ^a   Vikulina, Tatyana ^a   Zimring, James C ^a   Hillyer, Christopher D ^a  

^a Center for Transfusion and Cellular Therapies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ACUTE LUNG INJURY; ANTIGEN ANTIBODY REACTION; ARTICLE; BAGG ALBINO MOUSE; BLOOD TRANSFUSION REACTION; CELL ACTIVATION; EX VIVO STUDY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; GRANULOCYTE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN;

ACUTE LUNG INJURY; ANIMALS; BLOOD TRANSFUSION; DISEASE MODELS, ANIMAL; HUMANS;

EID: 56849127683     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2008.09.002     Document Type: Article

References (55)

1. Barnard R.D. Indiscriminate transfusion: A critique of case reports illustrating hypersensitivity reactions. N Y State J Med 51 (1951) 2399-2402
2. Brittingham T., and Chaplin Jr. H. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. JAMA 165 (1957) 819-825
3. Finlay H.E., Cassorla L., Feiner J., et al. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol 124 (2005) 601-609
4. Kopko P.M., and Holland P.V. Transfusion-related acute lung injury. Br J Haematol 105 (1999) 322-329
5. Kopko P.M., Marshall C.S., MacKenzie M.R., et al. Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA 287 (2002) 1968-1971
6. Finlay-Morreale H.E., Louie C., and Toy P. Computer-generated automatic alerts of respiratory distress after blood transfusion. J Am Med Inform Assoc 15 (2008) 383-385
7. Goldman M., Webert K.E., Arnold D.M., et al. Proceedings of a consensus conference: Towards an understanding of TRALI. Transfus Med Rev 19 (2005) 2-31
8. Silliman C.C., Ambruso D.R., and Boshkov L.K. Transfusion-related acute lung injury. Blood 105 (2005) 2266-2273
9. Kleinman S., Caulfield T., Chan P., et al. Toward an understanding of transfusion-related acute lung injury: Statement of a consensus panel. Transfusion 44 (2004) 1774-1789
10. Cherry T., Steciuk M., Reddy V.V., et al. Transfusion-related acute lung injury: Past, present, and future. Am J Clin Pathol 129 (2008) 287-297
11. Holness L., Knippen M.A., Simmons L., et al. Fatalities caused by TRALI. Transfus Med Rev 18 (2004) 184-188
12. Sheppard C.A., Logdberg L.E., Zimring J.C., et al. Transfusion-related acute lung injury. Hematol Oncol Clin North Am 21 (2007) 163-176
13. Philipps E., and Fleischner F.G. Pulomonary edema in the course of a blood transfusion without overloading the circulation. Diseases of the Chest 50 (1966) 619-623
14. Thompson J.S., Severson C.D., Parmely M.J., et al. Pulmonary "hypersensitivity" reactions induced by transfusion of non-HL-A leukoagglutinins. N Engl J Med 284 (1971) 1120-1125
15. Ward H.N. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 73 (1970) 689-694
16. Popovsky M.A., and Moore S.B. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25 (1985) 573-577
17. Curtis B.R., and McFarland J.G. Mechanisms of transfusion-related acute lung injury (TRALI): Anti-leukocyte antibodies. Crit Care Med 34 (2006) S118-S123
18. Kopko P.M. Leukocyte antibodies and biologically active mediators in the pathogenesis of transfusion-related acute lung injury. Curr Hematol Rep 3 (2004) 456-461
19. Silliman C.C., Boshkov L.K., Mehdizadehkashi Z., et al. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood 101 (2003) 454-462
20. Silliman C.C., Bjornsen A.J., Wyman T.H., et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 43 (2003) 633-640
21. Bux J., and Sachs U.J. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136 (2007) 788-799
22. Silliman C.C. The two-event model of transfusion-related acute lung injury. Crit Care Med 34 (2006) S124-S131
23. Kopko P.M., Popovsky M.A., MacKenzie M.R., et al. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 41 (2001) 1244-1248
24. Kopko P.M., Paglieroni T.G., Popovsky M.A., et al. TRALI: Correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 43 (2003) 177-184
25. Nishimura M., Hashimoto S., Satake M., et al. Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR. Vox Sang 93 (2007) 78-82
26. Nishimura M., Hashimoto S., Takanashi M., et al. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 17 (2007) 129-134
27. Wakamoto S., Fujihara M., Sakagawa H., et al. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody. Transfusion 48 (2008) 2060-2068
28. Middelburg R.A., van Stein D., Briet E., et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: A systematic review. Transfusion 48 (2008) 2167-2176
29. Bux J., Becker F., Seeger W., et al. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 93 (1996) 707-713
30. Popovsky M.A., Chaplin Jr. H.C., and Moore S.B. Transfusion-related acute lung injury: A neglected, serious complication of hemotherapy. Transfusion 32 (1992) 589-592
31. Wyman T.H., Bjornsen A.J., Elzi D.J., et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: Requirements for adherence and chemokine release. Am J Physiol Cell Physiol 283 (2002) C1592-C1603
32. Khan S.Y., Kelher M.R., Heal J.M., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108 (2006) 2455-2462
33. Silliman C.C., Curtis B.R., Kopko P.M., et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 109 (2007) 1752-1755
34. Seeger W., Schneider U., Kreusler B., et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 76 (1990) 1438-1444
35. Sachs U.J., Hattar K., Weissmann N., et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 107 (2006) 1217-1219
36. Silliman C.C., Voelkel N.F., Allard J.D., et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 101 (1998) 1458-1467
37. Looney M.R., and Matthay M.A. Animal models of transfusion-related acute lung injury. Crit Care Med 34 (2006) S132-S136
38. Vlaar A.P., Zweers M.M., Schultz M.J., et al. Developing specific therapeutic strategies for transfusion-related acute lung injury. An overview of potentially useful animal models. Cardiovasc Hematol Agents Med Chem 5 (2007) 319-326
39. Ashbaugh D.G., Bigelow D.B., Petty T.L., et al. Acute respiratory distress in adults. Lancet 2 (1967) 319-323
40. Kabir K., Gelinas J.P., Chen M., et al. Characterization of a murine model of endotoxin-induced acute lung injury. Shock 17 (2002) 300-303
41. Ritter C., da Cunha A.A., Echer I.C., et al. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med 34 (2006) 471-477
42. Rabinovici R., Bugelski P.J., Esser K.M., et al. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol 74 (1993) 1791-1802
43. Salzer W.L., and McCall C.E. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest 85 (1990) 1135-1443
44. Hicks W., Susskind B., Strait R., et al. Pathogenesis of transfusion related acute lung injury (TRALI) in an in vivo murine model. Hum Immunol 65 (2004) S10 [abstr]
45. Hicks W.A., Susskind B., Strait R., et al. In vivo murine model of transfusion-related acute lung injury. Transfusion 44 (2004) 23A [abstr]
46. Strait R., Susskind B., and Finkelman F. Murine TRALI: 1-Hit vs. 2-Hit model. Hum Immunol 66 (2005) S18 [abstr]
47. Strait R.T., Hicks W., Susskind B.M., et al. Murine model of transfusion related acute lung injury (TRALI) due to anti-MHC. Hum Immunol 64 (2003) S43 [abstr]
48. Strait R.T., Hicks W., Woodrich T., et al. One- and two-hit mouse models of transfusion-related acute lung injury (TRALI). FASEB J 19 (2005) A1508
49. Finkelman F: 2005 (pers commun).
50. Looney M.R., Su X., Van Ziffle J.A., et al. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 116 (2006) 1615-1623
51. Looney M.R., Barbeau R., Barczak A., et al. Microarray analysis of a mouse model of transfusion-related acute lung injury (TRALI) reveals prominent increased expression of neutrophil-derived chemokines. FASEB J 21 (2007) 894.9 [abstr]
52. Looney M.R., Lowell C.A., and Matthay M.A. Platelets are sequestered in the lungs of experimental transfusion-related acute lung injury (TRALI) and platelet depletion protects mice from TRALI. Thorax 62 (2007) A62 [abstr]
53. Strait R: 2007 (pers commun).
54. Silliman C.C., Mansuno T., Kelher M., et al. An in vivo two-event model of transfusion-related acute lung injury. Transfusion 46 (2006) 93A [abstr]
55. Silliman C.C., Kehler M., Mansuno T., et al. A two-event in vivo model of transfusion-related acute lung injury. Blood 108 (2006) 10a [abstr]